Terminology Service for NFDI4Health
MART-1:27-35 Peptide Vaccine
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2775
A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide. [ ]
Term info
Label
MART-1:27-35 Peptide Vaccine
Synonyms
- MART-1:27-35 Peptide
- MART-1:27-35 Peptide Vaccine
Subsets
NCIT_C116978, NCIT_C128784, NCIT_C116977
Contributing Source
CTRP
Display Name
MART-1:27-35 Peptide Vaccine
Legacy Concept Name
MART-1_27-35_PEPTIDE
NSC Code
672643
PDQ Closed Trial Search ID
476336
PDQ Open Trial Search ID
476336
Preferred Name
MART-1:27-35 Peptide Vaccine
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
UMLS CUI
C1831795
code
C2775
Term relations
Subclass of:
- Peptide Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Affects_Abnormal_Cell some Melanoma Cell
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation